Symbiotec Pharmalab Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 33.28% of Symbiotec Pharmalab, FIIs hold 3.79%, DIIs hold 33.17% and the public holds 29.77%.
Get an alert when Symbiotec Pharmalab reports results or its shareholding changes. Free account.
Promoters
33.28%
FIIs
3.79%
DIIs
33.17%
Public
29.77%
Value of the promoter stake
At a market capitalisation of ₹10.35k cr, the promoter group's 33.28% stake is worth ₹3.45k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Symbiotec Pharmalab shareholding: common questions
What is the promoter holding in Symbiotec Pharmalab?
Promoters hold 33.28% of Symbiotec Pharmalab as of Sep 2026.
How much do FIIs hold in Symbiotec Pharmalab?
Foreign institutional investors (FIIs) held 3.79% of Symbiotec Pharmalab in Sep 2026.
How much do mutual funds and other DIIs hold in Symbiotec Pharmalab?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 33.17% of Symbiotec Pharmalab in Sep 2026.
Is the promoter holding in Symbiotec Pharmalab pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Symbiotec Pharmalab.
How many shareholders does Symbiotec Pharmalab have?
Symbiotec Pharmalab had 81,747 shareholders in Sep 2026.